Prostate Cancer Clinical Trial
Official title:
A Pilot Trial Evaluation of Ultrasound Elasticity/Tissue Strain-Hardening Imaging for Prostate Cancer in Patients Undergoing Radical Prostatectomy
The primary objective is to perform a pilot trial evaluation of a novel prostate ultrasound
imaging software utilizing tissue elasticity measurements to identify tumor foci among men
who will undergo radical prostatectomy for localized prostate cancer.
As a secondary objective, investigators will compare elasticity measured tumor foci volume
to the measured volume from radical prostatectomy pathologic examination.
Study Imaging:
As part of routine care, ultrasound scanning is commonly used to find the cancerous areas of
the prostate before the prostate is surgically removed. The ultrasound images are in black,
white, and gray, and the dark areas may show prostate cancer.
In this study, standard ultrasound scanning will still be done, but researchers want to test
another form of diagnostic imaging called tissue elastography.
Tissue elastography uses the same machine and probe as the ultrasound. The probe is gently
pushed through the rectum and into the prostate gland (similar to a digital rectal exam).
The ultrasound machine will use a special elastography software that is designed to scan the
prostate for differences in how hard the tissue is. Prostate cancer tissue may be harder
than surrounding tissue, and the images produced by tissue elastography are designed to show
these differences in hardness of tissue.
Screening:
Before you can join this study, the study staff will review the results of your most recent
prostate ultrasound and biopsy. This is a "screening" procedure to help the doctor decide if
you are eligible to take part in this study.
Study Procedures:
If you are found to be eligible to take part in this study, tissue elastography imaging will
be performed during your routine ultrasound before prostate surgery. The probe, once
inserted, will be gently pressed against the prostate a few times in order to perform the
tissue elastography. The routine ultrasound part of the procedure should take about 10
minutes, and the elastography should take about 10-15 minutes.
Length of Study Participation:
Your active participation in this study will be over after the tissue elastography imaging.
The routine ultrasound will be the main decision-making exam. However, if the tissue
elastography imaging shows something different and possibly related to your care, your
doctor will be informed.
After the prostate is removed and the tissue results are available, researchers will compare
the tissue results with the tissue elastography images. You will not receive the results of
the tissue elastography imaging, as the imaging is being used for research only.
This is an investigational study. The ultrasound machine and probe that are used for the
tissue elastography in this study are FDA approved for ultrasound scanning. Performing
tissue elastography for prostate cancer detection is investigational. At this time and for
this purpose, tissue elastography is only being performed in research.
Up to 60 patients will take part in this study. All will be enrolled at M. D. Anderson.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05540392 -
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
|
Phase 1/Phase 2 | |
Recruiting |
NCT05613023 -
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
|
Phase 3 | |
Recruiting |
NCT05156424 -
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03177759 -
Living With Prostate Cancer (LPC)
|
||
Completed |
NCT01331083 -
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT05540782 -
A Study of Cognitive Health in Survivors of Prostate Cancer
|
||
Active, not recruiting |
NCT04742361 -
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
|
Phase 3 | |
Completed |
NCT04400656 -
PROState Pathway Embedded Comparative Trial
|
||
Completed |
NCT02282644 -
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
|
N/A | |
Recruiting |
NCT06305832 -
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05761093 -
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
|
||
Completed |
NCT04838626 -
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
|
Phase 2/Phase 3 | |
Recruiting |
NCT03101176 -
Multiparametric Ultrasound Imaging in Prostate Cancer
|
N/A | |
Completed |
NCT03290417 -
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Completed |
NCT01497925 -
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
|
Phase 1 | |
Recruiting |
NCT03679819 -
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
|
||
Completed |
NCT03554317 -
COMbination of Bipolar Androgen Therapy and Nivolumab
|
Phase 2 | |
Completed |
NCT03271502 -
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
|
N/A |